Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 27;62(4):e01776-17.
doi: 10.1128/AAC.01776-17. Print 2018 Apr.

In Vitro Antibiotic Susceptibility Pattern of Non-diphtheriae Corynebacterium Isolates in Ontario, Canada, from 2011 to 2016

Alefiya Neemuchwala  1 , Deidre Soares  1 , Vithusha Ravirajan  1 , Alex Marchand-Austin  1 , Julianne V Kus #  1   2 , Samir N Patel #  3   2
Affiliations

In Vitro Antibiotic Susceptibility Pattern of Non-diphtheriae Corynebacterium Isolates in Ontario, Canada, from 2011 to 2016

Alefiya Neemuchwala et al. Antimicrob Agents Chemother. .

Abstract

Non-diphtheriae Corynebacterium-associated disease has been increasingly observed and often presents a conundrum to the treating physician. Analysis of antibiotic susceptibility testing data for 1,970 clinical Corynebacterium isolates received between 2011 and 2016 revealed that empirical drug treatment options are limited to vancomycin and linezolid. Corynebacterium striatum was the most frequently observed species during this study period, along with C. amycolatum and C. pseudodiphtheriticum/C. propinquum Low levels of susceptibility to penicillin (14.5%), erythromycin (15.1%), and clindamycin (8.7%) were observed for non-diphtheriae Corynebacterium species, while 3.0% of isolates were not susceptible to daptomycin. Similarly, 26.9% and 38.1% of Corynebacterium isolates were susceptible to ciprofloxacin and trimethoprim-sulfamethoxazole, respectively. Our data show much lower susceptibility to penicillin than previously reported in the literature and an increasing number of isolates resistant to daptomycin, highlighting the need for continued antibiotic surveillance studies for appropriate patient management and treatment success.

Keywords: Corynebacterium; antibiotic resistance; penicillin resistance; susceptibility testing.

PubMed Disclaimer

References

    1. Funke G, von Graevenitz A, Clarridge JE III, Bernard KA. 1997. Clinical microbiology of coryneform bacteria. Clin Microbiol Rev 10:125–159. - PMC - PubMed
    1. Hahn WO, Werth BJ, Butler-Wu SM, Rakita RM. 2016. Multidrug-resistant Corynebacterium striatum associated with increased use of parenteral antimicrobial drugs. Emerg Infect Dis 22:1908–1914. doi:10.3201/eid2211.160141. - DOI - PMC - PubMed
    1. Bernard K. 2012. The genus Corynebacterium and other medically relevant coryneform-like bacteria. J Clin Microbiol 50:3152–3158. doi:10.1128/JCM.00796-12. - DOI - PMC - PubMed
    1. Bernard K, Pacheco AL. 2015. In vitro activity of 22 antimicrobial agents against Corynebacterium and Microbacterium species referred to the Canadian National Microbiology Laboratory. Clin Microbiol Newsletter 37:187–198. doi:10.1016/j.clinmicnews.2015.11.003. - DOI
    1. Funke G, Bernard K. 2011. Coryneform Gram-positive rods, p 413–42. In Versalovic J, Caroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW (ed), Manual of clinical microbiology, 10th ed, vol 1 ASM Press, Washington, DC.

MeSH terms

LinkOut - more resources